Literature DB >> 5821186

Agnogenic myeloid metaplasia: role of splenectomy.

C Marks, M Ahmadi.   

Abstract

Entities:  

Mesh:

Year:  1969        PMID: 5821186      PMCID: PMC2466587          DOI: 10.1136/pgmj.45.522.261

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  SPLENECTOMY FOR AGNOGENIC MYELOID METAPLASIA AND MYELOFIBROSIS.

Authors:  N FISHMAN; W F BALLINGER
Journal:  Arch Surg       Date:  1965-02

2.  Red-cell production and destruction in myelosclerosis.

Authors:  L SZUR; M D SMITH
Journal:  Br J Haematol       Date:  1961-04       Impact factor: 6.998

3.  Agnogenic myeloid metaplasia: its natural history and present day management.

Authors:  F H BETHELL; J W LINMAN
Journal:  Am J Med       Date:  1957-01       Impact factor: 4.965

4.  Polycythemia vera: its course and treatment; relation to myeloid metaplasia and leukemia.

Authors:  L R WASSERMAN
Journal:  Bull N Y Acad Med       Date:  1954-05

5.  The myeloproliferative disorders with special reference to myelofibrosis.

Authors:  M S R HUTT; J L PINNIGER; G WETHERLEY-MEIN
Journal:  Blood       Date:  1953-04       Impact factor: 22.113

6.  Splenectomy for myeloid metaplasia of the spleen.

Authors:  T W GREEN; C L CONLEY; L L ASHBURN; H R PETERS
Journal:  N Engl J Med       Date:  1953-02-05       Impact factor: 91.245

7.  Some speculations on the myeloproliferative syndromes.

Authors:  W DAMESHEK
Journal:  Blood       Date:  1951-04       Impact factor: 22.113

8.  Chronic marrow failure, myelosclerosis and extramedullary hematopoiesis.

Authors:  J P WYATT; S C SOMMERS
Journal:  Blood       Date:  1950-04       Impact factor: 22.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.